ProQR Therapeutics (PRQR) Total Debt (2021 - 2025)
Historic Total Debt for ProQR Therapeutics (PRQR) over the last 4 years, with Q4 2024 value amounting to $4.9 million.
- ProQR Therapeutics' Total Debt rose 602.8% to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.9 million, marking a year-over-year increase of 602.8%. This contributed to the annual value of $5.0 million for FY2024, which is 681.8% up from last year.
- ProQR Therapeutics' Total Debt amounted to $4.9 million in Q4 2024, which was up 602.8% from $4.6 million recorded in Q4 2023.
- ProQR Therapeutics' 5-year Total Debt high stood at $50.4 million for Q4 2021, and its period low was $19910.1 during Q1 2021.
- In the last 4 years, ProQR Therapeutics' Total Debt had a median value of $4.9 million in 2024 and averaged $16.0 million.
- Per our database at Business Quant, ProQR Therapeutics' Total Debt skyrocketed by 21618109.17% in 2022 and then plummeted by 9034.26% in 2023.
- ProQR Therapeutics' Total Debt (Quarter) stood at $50.4 million in 2021, then crashed by 86.3% to $6.9 million in 2022, then plummeted by 33.15% to $4.6 million in 2023, then rose by 6.03% to $4.9 million in 2024.
- Its Total Debt was $4.9 million in Q4 2024, compared to $4.6 million in Q4 2023 and $3.1 million in Q3 2023.